# A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer

> **NCT06709872** · — · ACTIVE_NOT_RECRUITING · sponsor: **KU Leuven** · enrollment: 400 (estimated)

## Conditions studied

- Stage I Ovarian Cancer
- Borderline Ovarian Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06709872
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-03
- **Primary completion:** 2029-09-03
- **Final completion:** 2029-09-03
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06709872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06709872, "A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06709872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*